Gary Mangiofico, Ph.D.

While CVS argues that its CostVantage model will provide more transparency and clarity in the pricing of drugs, there is no accompanying statement that this will lower drug prices.

Outsourcing is not the end-all solution, but it is a critical ingredient for navigating transorganizational opportunities to improve the healthcare ecosystem, argues Gary Mangiofico, Ph.D., of the Pepperdine Graziadio Business School.